Newly Diagnosed Multiple Myeloma Recruiting Phase 2 / 3 Trials for Isatuximab (DB14811)

Also known as: Newly Diagnosed Multiple Myeloma (NDMM) / Newly Diagnosed, Multiple Myeloma / Multiple Myeloma, Newly Diagnosed

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05665140Expression-linked and R-ISS-adapted Stratification for First Line Therapy in Multiple Myeloma PatientsTreatment